Florida officials weigh in on the federal rescheduling of medical marijuana

Florida officials and medical marijuana industry representatives discuss the potential impact of federal rescheduling of cannabis from Schedule I to Schedule III. The change, ordered by U.S. Attorney General Todd Blanche, aims to facilitate research and product development by allowing access to state-licensed medical marijuana products. Industry leaders highlight benefits such as expanded trials, improved dosing guidance, and reduced financial uncertainty for licensed operators.